Primary study · included by 1 review
Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study.
Eisele 2021 · Eisele Yannick, Mallea Patrick M, Gigic Biljana, et al. · Clinical colorectal cancer · 2021
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Overall survival High intratumoral or fecal Fusobacterium nucleatum load vs Low or no F. nucleatum | HR 1.52 [1.07, 2.16] | 4 studies | GRADE not reported |
1 including review in total.